__NUXT_JSONP__("/drugs/Depatuxizumab_Mafodotin", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1585973-65-4",chebiId:b,chemicalFormula:b,definition:"An epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon intravenous infusion, depatuxizumab mafodotin inhibits the activity of EGFR, thereby preventing EGFR-mediated signaling. This may inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase overexpressed in certain tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization.",fdaUniiCode:"F3R7A4P04N",identifier:"C105612",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C2167"],synonyms:["ABT-414","DEPATUXIZUMAB MAFODOTIN",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FDepatuxizumab_Mafodotin",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Depatuxizumab_Mafodotin","","Depatuxizumab Mafodotin","2021-10-30T13:17:46.913Z")));